View of Role of Ormeloxifene (SERM) in Treatment of Fibrocystic Breast Disease in patients aged 18-50 years in a tertiary care hospital in Chennai.

Return to Article Details Role of Ormeloxifene (SERM) in Treatment of Fibrocystic Breast Disease in patients aged 18-50 years in a tertiary care hospital in Chennai. Download Download PDF